Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma.
Sun H, Liu SY, Zhou JY, Xu JT, Zhang HK, Yan HH, Huan JJ, Dai PP, Xu CR, Su J, Guan YF, Yi X, Yu RS, Zhong WZ, Wu YL.
Sun H, et al. Among authors: wu yl.
EBioMedicine. 2020 Oct;60:102990. doi: 10.1016/j.ebiom.2020.102990. Epub 2020 Sep 11.
EBioMedicine. 2020.
PMID: 32927274
Free PMC article.